Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novamind Inc. NVMDF

Healthcare Biotechnology
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence... see more

Recent & Breaking News (OTCQB:NVMDF)

CSE Bulletin: Delist -Novamind Inc. (NM)

Newsfile June 13, 2022

IIROC Trading Halt - NM

Canada NewsWire June 13, 2022

Novamind Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.

Accesswire June 10, 2022

Novamind Shareholders Approve Proposed Acquisition by Numinus

Accesswire June 8, 2022

Novamind Announces New Patient Financing Options

Accesswire June 2, 2022

Novamind Reports Fiscal Q3 2022 Financial Results and Operating Highlights

Accesswire May 31, 2022

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders of Novamind Vote FOR the Proposed Plan of Arrangement

Accesswire May 27, 2022

The StockTalk Cannabis Report: May 20, 2022

Dave Jackson May 20, 2022

Novamind Launches Group Psychedelic Treatment for Frontline Workers

Accesswire May 19, 2022

Novamind Files Management Information Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement

Accesswire May 11, 2022

Novamind to Host Bionomics' PREVAIL Trial for Acute Treatment of Social Anxiety Disorder

Accesswire May 10, 2022

Novamind Announces Virtual Group Health Coaching

Accesswire May 2, 2022

The StockTalk Cannabis Report: April 15, 2022

Dave Jackson April 15, 2022

North America’s New Industry Leader in Psychedelic Therapy & Research

Stockhouse Editorial April 12, 2022

IIROC Trade Resumption - NM

Canada NewsWire April 12, 2022

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Accesswire April 12, 2022

IIROC Trading Halt - NM

Canada NewsWire April 11, 2022

Novamind Opens 8th Integrative Psychiatry Clinic

Accesswire April 6, 2022

Novamind Partner to Acquire Specialized Ibogaine Group in Brazil

Accesswire March 31, 2022

Novamind Expands Group Therapy Model

Accesswire March 24, 2022